Đang chuẩn bị liên kết để tải về tài liệu:
Safety evaluation of the interchangeable use of robenacoxib in commerciallyavailable tablets and solution for injection in cats

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Robenacoxib (Onsior™) is a non-steroidal anti-inflammatory drug developed for canine and feline use for the control of pain and inflammation. It is available as both tablets and solution for injection. The objective of this study was to evaluate the safety of the interchangeable use of commercially available robenacoxib formulations when administered to cats orally using 6 mg tablets and subcutaneously using a solution for injection containing 20 mg/mL. |

TÀI LIỆU LIÊN QUAN

Safety evaluation of poultry feed using immuno sorbent assay technique

Antimicrobial activity and safety evaluation of Enterococcus faecium KQ 2.6 isolated from peacock feces

Summary of PhD thesis in Medicine: Evaluation of HS-CRP, IL-17A levels, and efficacyand safety ofsecukinumab in patients with psoriasis vulgaris

Safety Evaluation Of Certain Food Additives

Evaluation of implementation of health and safety in industry and vocational school in Yogyakarta special region

Evaluation of the Patient Safety Improvement Corps

Assessment of the AHRQ Patient Safety Initiative

THE INVESTIGATION ABOUT THE SUCCESS OF THE SAFETY BUS IN TYNE AND WEAR UNIVERSITY (TWU)

Collapse safety margin in iranian seismic design code: Case studies of RC frame structuress

Safety Evaluation of Medical Devices Second Edition Revised and Expanded
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.